- Home
- FITBM vs NBIX Comparison
FITBM vs NBIX Comparison
Compare FITBM & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
FITBM
Fifth Third Bancorp Depositary Shares Representing a 1/40th Ownership Interest in a Share of 6.875% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series M
Current Price
Company Overview
Basic Information| Metric | FITBM | NBIX |
|---|---|---|
| Founded | N/A | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.2B | 13.9B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | FITBM | NBIX |
|---|---|---|
| Price | $26.05 | $132.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 22 |
| Target Price | N/A | ★ $175.23 |
| AVG Volume (30 Days) | 149.9K | ★ 1.2M |
| Earning Date | N/A | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 41.95 |
| EPS | N/A | ★ 4.67 |
| Revenue | N/A | ★ $161,626,000.00 |
| Revenue This Year | N/A | $22.57 |
| Revenue Next Year | N/A | $9.56 |
| P/E Ratio | ★ N/A | $28.29 |
| Revenue Growth | N/A | ★ 977.51 |
| 52 Week Low | $25.95 | $84.23 |
| 52 Week High | $26.49 | $160.18 |
Technical Indicators
Market Signals| Indicator | FITBM | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 56.24 | 48.30 |
| Support Level | $26.17 | $122.82 |
| Resistance Level | $26.49 | $137.37 |
| Average True Range (ATR) | 0.22 | 4.05 |
| MACD | -0.03 | 0.43 |
| Stochastic Oscillator | 59.46 | 49.43 |
Price Performance
Historical ComparisonAbout NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.